CN Patent

CN111888477B — 一种贝达喹啉药物制剂

Assigned to Beijing Fuyuan Pharmaceutical Co ltd · Expires 2023-03-07 · 3y expired

What this patent protects

本发明提供一种贝达喹啉药物制剂，包含贝达喹啉固体组合物和辅料，所述贝达喹啉固体组合物包含贝达喹啉或其药学上可接受的盐，酸化剂和粘合剂。本发明制得的贝达喹啉药物制剂旨在克服贝达喹啉溶出效果差的问题，其具有较好的溶出度，得到产品质量符合标准要求，适合工业大规模生产。

USPTO Abstract

本发明提供一种贝达喹啉药物制剂，包含贝达喹啉固体组合物和辅料，所述贝达喹啉固体组合物包含贝达喹啉或其药学上可接受的盐，酸化剂和粘合剂。本发明制得的贝达喹啉药物制剂旨在克服贝达喹啉溶出效果差的问题，其具有较好的溶出度，得到产品质量符合标准要求，适合工业大规模生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN111888477B
Jurisdiction
CN
Classification
—
Expires
2023-03-07
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Fuyuan Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.